Small aortic root in aortic valve stenosis: clinical characteristics and prognostic implications

Eur Heart J Cardiovasc Imaging. 2017 Apr 1;18(4):404-412. doi: 10.1093/ehjci/jew159.

Abstract

Aims: In aortic valve stenosis (AS), having a small aortic root may influence both the assessment of AS severity and the treatment strategy. The aim was to test the prognostic implications of having a small aortic root in AS within a large prospective study.

Methods and results: We used data from 4.3-year follow-up of 1560 patients with asymptomatic, initially mostly moderate AS enrolled in the Simvastatin and Ezetimibe in Aortic Stenosis study. A small aortic root was defined as inner aortic sinotubular junction diameter indexed for body height <1.4 cm/m in women and <1.5 cm/m in men. A small aortic root was found in 270 patients (17.3%) at baseline. Having a small aortic root was associated with larger aortic root wall thickness, higher pressure recovery, lower systemic arterial compliance, left ventricular mass index, and female sex in a multivariable logistic regression analysis (all P < 0.05). In the Cox regression analysis, having a small aortic root at baseline was associated with higher hazard rates of ischaemic cardiovascular events (n = 268; HR 1.55, 95% CI 1.16-2.06), non-haemorrhagic stroke (n = 55; HR 1.88, 95% CI 1.04-3.41), and cardiovascular death (n = 81; HR 2.08, 95% CI 1.28-3.39) (all P < 0.05) after adjusting for confounders, including randomized study treatment, sex, hypertension, AS severity, and aortic valve replacement.

Conclusion: In AS patients without known cardiovascular disease or diabetes, having a small aortic root was associated with increased ischaemic cardiovascular events and mortality. The results suggest a relation between the presence of a small aortic root and that of subclinical atherosclerosis.

Clinical trial registration: ClinicalTrials.gov identifier: NCT00092677.

Keywords: aortic valve stenosis; energy loss index; prognosis; small aortic root.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Aortic Valve / diagnostic imaging*
  • Aortic Valve / drug effects
  • Aortic Valve Stenosis / diagnostic imaging*
  • Aortic Valve Stenosis / drug therapy*
  • Aortic Valve Stenosis / mortality
  • Aortic Valve Stenosis / physiopathology
  • Echocardiography
  • Ezetimibe / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Simvastatin / therapeutic use*
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Substances

  • Simvastatin
  • Ezetimibe

Associated data

  • ClinicalTrials.gov/NCT00092677